Results 71 to 80 of about 9,802 (262)

Guided Bone Regeneration (GBR) for Reconstructing Alveolar Bone Defects Following Resective Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ) Lesions: A Case Series. [PDF]

Clin Case Rep
This composite figure illustrates some of the clinical and radiographic features of medication‐related osteonecrosis of the jaw (MRONJ), including panoramic, intraoral, axial CBCT, and extraoral images highlighting intra‐oral to bone probing, radiographic lysis, sequestration and periosteal reaction, and facial swelling.
Masri D, Ghanaiem O, Raiser V, Adut S, Chaushu G.   +4 more
europepmc   +2 more sources

Machine learning methods for predicting adverse drug events: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, Sheikh S. Abdullah, Neda Rostamzadeh, Atefeh Jafari, Lujain Izzedin, Kamran Sedig, Flory T. Muanda   +8 more
wiley   +1 more source

Histology of the Oral Mucosa in Patients With BRONJ at III Stage: A Microscopic Study Proves the Unsuitability of Local Mucosal Flaps. [PDF]

, 2013
BACKGROUND: Bisphosphonate Osteonecrosis of the Jaw (BRONJ) is a newly recognized condition reported in patients treated with aminobisphosphonates (BF).
CORDOVA, Adriana, CORRADINO, Bartolo, DI LORENZO, Sara, Trapassi, A   +3 more
core   +1 more source

Soluble Sema4D From γδ T Cells Exerts Osteoblast Inhibition via Plexin‐B/mTOR Signalling Contributing to Pathogenesis of Bisphosphonate‐Related Osteonecrosis of the Jaws

Cell Proliferation, EarlyView.
Schematic summarizing the pathway of sSema4D from γδ T cells inhibiting osteoblast differentiation in BRONJ. ABSTRACT Bisphosphonate‐related osteonecrosis of the jaw (BRONJ) is a severe complication in patients undergoing long‐term bisphosphonate therapy, while our knowledge on the pathogenesis of BRONJ is far from sufficient.
Lingling Ou, Shijia Qiao, Zhuoyi Liao, Xiner Tan, Hui Huang, Zhiyan Zhou, Ruhui Luo, Weijun Zeng, Yan Yang, Zhongxuan Zhang, Jingchen Chen, Shengli Wang, Yiqin Jiang, Jianlei Hao, Yuqin Shen, Longquan Shao   +15 more
wiley   +1 more source

Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis : a comparative study [PDF]

, 2009
Aims: We analyze the possible clinical differences between bone jaw exposed areas in ONJ (osteonecrosis of the jaws) and ORN (osteoradionecrosis). Patients and method: Group 1 was composed with 53 ONJ cases and group 2 with 20 ORN cases. In both groups
Bagán Sebastián, José Vicente, Carbonell Pastor, Enrique, Díaz Fernández, José María, Gavaldá Esteve, Carmen, Hernández Bazán, Sergio, Jiménez Soriano, Yolanda, Murillo Cortés, Judith, Poveda Roda, Rafael, Sanchís Bielsa, José María, Scully, Crispian   +9 more
core   +1 more source

ONCOllab for Transmission of Knowledge Related to Oral Complications of Cancer Therapy Among Dental Students

European Journal of Dental Education, EarlyView.
ABSTRACT Introduction ONCOllab is a social media application developed by FDI to improve the management of oral complications that may arise during cancer therapy. This study aimed to evaluate the effects of ONCOllab on learning and perception among dental students.
Sara Samur Erguven, Paul L. Friedlander, Dilber Celik, Aydin Ozkan   +3 more
wiley   +1 more source

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review

São Paulo Medical Journal, 2020
BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is still the most prevalent type of osteonecrosis with clinical relevance. In Brazil, bisphosphonate use is high but there is a lack of epidemiological studies on BRONJ. OBJECTIVE: To
Aloizio Premoli Maciel, Reyna Aguilar Quispe, Lázara Joyce Oliveira Martins, Rogério Jardim Caldas, Paulo Sérgio da Silva Santos   +4 more
doaj   +1 more source

Absence of medication-related jaw osteonecrosis after treatment with strontium ranelate in ovariectomized rats

Brazilian Oral Research, 2022
This study aimed to evaluate the potential of strontium ranelate (SR) in medication-related jaw osteonecrosis (MRONJ) after tooth extraction in ovariectomized rats.
Leomar Emanuel de Almeida MECCA, Amanda Regina FISCHBORN, Jessica Daniela ANDREIS, Gabrielle DELFRATE, Tayline MROCZEK, Natália Mariane RIGO, Fábio Brasil de OLIVEIRA, Myrella Lessio CASTRO, Mario TABA JUNIOR, Marcela CLAUDINO, Gilson Cesar Nobre FRANCO   +10 more
doaj   +1 more source

Alterations of bone proteins in medication‐related osteonecrosis of the jaw

European Journal of Oral Sciences, Volume 133, Issue 2, April 2025.
Abstract Changes in the protein expression pattern of osteoblastic lineage cells from the alveolar bone (OLAB) during medication‐related osteonecrosis of the jaw (MRONJ) have rarely been investigated. This lack of information is partly because of the limited availability of healthy samples and the lack of human alveolar bone cell lines for research ...
Andrea Schubert, Phillipp Brockmeyer, Philipp Kauffmann, Jan Wiegel, Florian Lautenbacher, Nicolai Miosge, Boris Schminke   +6 more
wiley   +1 more source

Acute Nontraumatic Clavicle Fracture Associated with Long-Term Bisphosphonate Therapy

Case Reports in Orthopedics, 2014
Cases of osteonecrosis of the jaw, insufficiency fractures and atypical low energy or atraumatic fractures of pelvis, femur (subtrochanteric/mid-shaft/distal-third), tibia, fibula, metatarsal, humerus, and ulna related to long-term bisphosphonate therapy
Shen Hwa Vun, Yahya Husami, Sajan Shareef, Diane Bramley   +3 more
doaj   +1 more source